Conatus Pharmaceuticals Competitors and Similar CompaniesClear all
Conatus Pharmaceuticals's competitors and similar companies include Vertex Pharmaceuticals, Biogen, Cadila Pharmaceuticals and Fujifilm Diosynth Biotechnologies.
 Conatus Pharmaceuticals Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. |  Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. | |
Founding Date | Founding Date 2005 | Founding Date 1989 | Founding Date 1978 | Founding Date 1951 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US | ||
Employees | Employees 309% decrease | Employees 5,40013% increase | Employees 7,605 | Employees 8,5201% increase | Employees 5,3942% increase |
Valuation ($) | Valuation ($) 18.4 m | Valuation ($) 121.4 b | Valuation ($) 26.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $3.8m (FY, 2022) | Revenue (est.) $12b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.7b (FY, 2025) | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $10.4b (FY, 2025) | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($10.6m) (FY, 2022) | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 28.6m | Total funding raised $ 2.4m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 850m |
For sources of this data, please see the company profile
View Company Profiles
Vertex Pharmaceuticals
HQ
Boston, US
Employees
5,400↑ 13% increase
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyFujifilm Diosynth Biotechnologies
HQ
Morrisville, US
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View company